Samuel Shepherd

Samuel Shepherd is a Senior Scientist working in the Analytical Sciences group within the department of Biopharmaceutical Development at Astrazeneca Cambridge UK.
Sam has a passion for science with interests in automation and process improvement, to drive the development of high quality pharmaceuticals, getting them to where they are needed. With the patient.

Sam gained a 2:1 Honours degree in Biomedical Sciences from Durham University in 2010, with his dissertation looking into the impact of cardiac events on the baroreceptor reflex in controlling blood pressure. This included an industrial placement completed at Avecia Biologics Ltd in fermentation R&D, working with Pichia and E. coli from 5L to 100L scale.

After graduating he worked for CRO Huntingdon Life Sciences developing and validating a range of ligand binding and flow cytometry assays in support of pre-clinical and clinical trials. Within this role he gained experience with a range of instrument formats including Luminex, MSD and Gyros to increase throughput, automation and data output through multiplexing.

In 2013 he made the move to MedImmune, the biologics R&D arm of AstraZeneca, to work within the Analytical Sciences function of Biopharmaceutical Development. Sam has a broad knowledge base in physicochemical and characterisation analytics, which he leverages to work collaboratively with Research, Development functions, and GMP. His role in Biopharmaceutical Development contributes towards the progression of biologics through the pipeline from assessments of developability, through Phase I supporting IND submissions, and into Phase II.